Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7389 p221-226
25 February 2006

This section
Reprint   Photocopy

PDF 150K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

221 Do not get left behind, NHS CfH warns contractors Pharmacy contractors who unduly delay becoming compliant with release 1 of the electronic prescription service (EPS) run the risk of being left behind when release 2 is deployed nationally, Tim Donohoe, group programme director for the National Programme for IT, told The Journal in an interview this week ...more

221 No evidence that PCTs slow to issue smartcards, says NHS CfH Pharmacy contractors should inform their supplier or NHS Connecting for Health if primary care trusts are slow to issue smartcards, Tim Donohoe, group programme director for the National Programme for IT, told The Journal earlier this week. However, he added that NHS CfH has not detected any particular evidence that PCTs have not been forthcoming with smartcards ...more

221 Pharmacy applications up but university applications down Applications for pharmacy courses are up by 9.6 per cent amid a general decline in the number of students applying to UK higher education institutions this year, according to the latest statistics from the Universities and Colleges Admissions Service (UCAS) ...more

222 Pharmacy oxygen supplies should continue Home oxygen provision should be opened up to allow community pharmacies to continue to provide cylinders to patients alongside the new supplier companies, the Pharmaceutical Services Negotiating Committee said last week ...more

222 Independent pharmacies threatened, say MPs Independent pharmacies stand only a moderate chance of still being in business in 2015, according to a Parliamentary report published last week ...more

222 Ximelagatran withdrawn due to liver safety concerns The oral anticoagulant ximelagatran (Exanta), a direct thrombin inhibitor, has been withdrawn from the market and its development has been terminated, AstraZeneca announced last week ...more

222 MA for Herceptin submitted Roche announced this week that it has submitted a marketing authorisation application to the European Medicines Agency for Herceptin (trastuzumab) as adjuvant treatment for early stage HER2-positive breast cancer ...more

223 Discharge guidance to reduce medicines-related risk Detailed guidance for those involved in moving patients between different health care settings has been launched by a group of pharmacy organisations with the aim of reducing medicines-related risks on admission, transfer or discharge ...more

223 Manslaughter investigation protocol agreed Police investigations into unexpected deaths or serious untoward harm in the NHS should only take place when there is clear evidence of a criminal offence having been committed ...more

223 Welsh innovations support Support for health professionals developing innovations for the NHS in Wales was announced by health minister Brian Gibbons last week ...more

223 Seizure and abnormal heart rhythm warning on atomoxetine Warnings on the risk of seizures and abnormal heart rhythm when taking atomoxetine (Strattera; Lilly) have been set out in a Medicines and Healthcare products Regulatory Agency letter to doctors ...more

223 Switch data exclusivity guidance Guidelines on how pharmaceutical companies can claim a year's data exclusivity on reclassifications of medicines from prescription-only to over-the-counter status have been published by the European Commission ...more

223 MPs welcome prescribing plans Plans for pharmacists to be able to prescribe independently have been welcomed by members of Parliament in an Early-Day Motion ...more

224 NICE releases nutrition guidance Pharmacists should be included in multidisciplinary teams providing nutrition support to patients in England and Wales, National Institute for Health and Clinical Excellence guidelines issued this week recommend ...more

224 Chronic hepatitis B treatments given thumbs up by NICE Newer treatments for chronic hepatitis B in adults have been recommended for use in the NHS in England and Wales by the National Institute for Health and Clinical Excellence ...more

224 Alternating paracetamol/ibuprofen regimen effectively lowers fever in children An alternating regimen of paracetamol and ibuprofen lowers fever faster than either drug alone in children aged six to 36 months, without increasing adverse effects, according to a paper ...more

224 Infection a risk with preservative-free drops Some patients using preservative-free eye drops in multiple-use containers could be at risk of serious eye infection due to microbial contamination of the product, according to the authors of a new study ...more

225 Role of antibiotic pharmacists gets doctors' support Support for hospital antibiotic pharmacists has been given this week in a report released by the British Medical Association ...more

225 Most pharmacists not confident in supply of prescription-only veterinary medicines Most pharmacists do not believe they are competent to supply prescription-only veterinary medicines, the results of a survey published last week suggest ...more

225 Society adviser becomes MP Willie Rennie, who has been public affairs adviser to the Royal Pharmaceutical Society in Scotland, has been elected to Parliament ...more

225 Generic exemption plan for prescription charges NHS managers have been discussing exempting prescriptions for generic medicines from the prescription charge ...more

225 Guidance for practice-based commissioning issued A booklet of top tips, practical ideas and case studies for use by GPs and other primary care staff to help them get involved in practice-based commissioning has been published by the Department of Health ...more

225 Health Acts to be consolidated The 14 Acts of Parliament that govern the NHS are to be consolidated into two Acts — one for England and one for Wales ...more

225 Monitoring ADRs New software has been introduced at the Medicines and Healthcare products Regulatory Agency to analyse reported adverse drug reactions ...more

226 Funding set to close paediatric dosing knowledge gap Little is currently being done to study prescribing and dosing errors in children in the UK, researchers have found in the preliminary stages of a new project being funded by the Department of Health ...more

226 Drug metabolism differs in children and adults Specific differences between children and adults in the types and levels of enzymes that metabolise drugs have now been identified by researchers ...more

226 World Health Organization calls for concrete international action on counterfeit medicines Immediate concrete action against the growing global epidemic of counterfeit medicines has been called for by the World Health Organization ...more

Back to Top


©The Pharmaceutical Journal